These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30864265)

  • 21. Lonely planet: Multicellular organisms.
    Häfner S
    Microbes Infect; 2016 Apr; 18(4):221-3. PubMed ID: 26774335
    [No Abstract]   [Full Text] [Related]  

  • 22. Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors.
    Rigottier-Gois L; Alberti A; Houel A; Taly JF; Palcy P; Manson J; Pinto D; Matos RC; Carrilero L; Montero N; Tariq M; Karsens H; Repp C; Kropec A; Budin-Verneuil A; Benachour A; Sauvageot N; Bizzini A; Gilmore MS; Bessières P; Kok J; Huebner J; Lopes F; Gonzalez-Zorn B; Hartke A; Serror P
    PLoS One; 2011; 6(12):e29023. PubMed ID: 22194979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options.
    M Campos JC; Antunes LC; Ferreira RB
    Future Microbiol; 2020 May; 15():649-677. PubMed ID: 32495702
    [No Abstract]   [Full Text] [Related]  

  • 24. Itaconimides as Novel Quorum Sensing Inhibitors of
    Fong J; Mortensen KT; Nørskov A; Qvortrup K; Yang L; Tan CH; Nielsen TE; Givskov M
    Front Cell Infect Microbiol; 2018; 8():443. PubMed ID: 30666301
    [No Abstract]   [Full Text] [Related]  

  • 25. Underestimated collateral effects of antibiotic therapy in prosthesis-associated bacterial infections.
    Baldassarri L; Montanaro L; Creti R; Arciola CR
    Int J Artif Organs; 2007 Sep; 30(9):786-91. PubMed ID: 17918123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry of bacterial multidrug efflux pumps.
    Kumar S; Varela MF
    Int J Mol Sci; 2012; 13(4):4484-4495. PubMed ID: 22605991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial type III effectors inhibit cell lifting by targeting integrin-linked kinase.
    Tegtmeyer N; Backert S
    Cell Host Microbe; 2009 Jun; 5(6):514-6. PubMed ID: 19527878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Molecules That Sabotage Bacterial Virulence.
    Johnson BK; Abramovitch RB
    Trends Pharmacol Sci; 2017 Apr; 38(4):339-362. PubMed ID: 28209403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host cell responses against the pseudomonal biofilm: A continued tale of host-pathogen interactions.
    Sankar S; Ganesh PS; Subramaniam S; Shankar EM; Yuwanati M; Govindasamy R; Thiruvengadam M
    Microb Pathog; 2023 Jan; 174():105940. PubMed ID: 36513294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-virulence Strategies to Target Bacterial Infections.
    Mühlen S; Dersch P
    Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common and pathogen-specific virulence factors are different in function and structure.
    Niu C; Yu D; Wang Y; Ren H; Jin Y; Zhou W; Li B; Cheng Y; Yue J; Gao Z; Liang L
    Virulence; 2013 Aug; 4(6):473-82. PubMed ID: 23863604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common themes in the design and function of bacterial effectors.
    Galán JE
    Cell Host Microbe; 2009 Jun; 5(6):571-9. PubMed ID: 19527884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
    Law SKK; Tan HS
    Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host-microbe interactions: bacteria.
    O'Callaghan D; Stebbins CE
    Curr Opin Microbiol; 2010 Feb; 13(1):1-3. PubMed ID: 20044300
    [No Abstract]   [Full Text] [Related]  

  • 35. Extracellular HtrA serine proteases: An emerging new strategy in bacterial pathogenesis.
    Backert S; Bernegger S; Skórko-Glonek J; Wessler S
    Cell Microbiol; 2018 Jun; 20(6):e12845. PubMed ID: 29582532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance, virulence factors and biofilm formation ability in Escherichia coli strains isolated from chicken meat and wildlife in the Czech Republic.
    Pavlickova S; Klancnik A; Dolezalova M; Mozina SS; Holko I
    J Environ Sci Health B; 2017 Aug; 52(8):570-576. PubMed ID: 28494209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Virulence Factors and Biofilm Formation by Wogonin Attenuates Pathogenicity of
    Wang S; Feng Y; Han X; Cai X; Yang L; Liu C; Shen L
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884499
    [No Abstract]   [Full Text] [Related]  

  • 38. Hijacking host components for bacterial biofilm formation: An advanced mechanism.
    Mirzaei R; Ranjbar R
    Int Immunopharmacol; 2022 Feb; 103():108471. PubMed ID: 34952466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biological cost of mutational antibiotic resistance: any practical conclusions?
    Andersson DI
    Curr Opin Microbiol; 2006 Oct; 9(5):461-5. PubMed ID: 16890008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting virulence: a new paradigm for antimicrobial therapy.
    Clatworthy AE; Pierson E; Hung DT
    Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.